Literature DB >> 8598461

B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching.

C M Snapper1, P Zelazowski, F R Rosas, M R Kehry, M Tian, D Baltimore, W C Sha.   

Abstract

To better understand the role of NF-kappaB in normal B cell physiology, we used a purified population of resting B cells from p50/NF-kappa B knockout (p50-/-) mice to determine their ability to proliferate, secrete Ig, express germ-line CHRNA, and undergo Ig isotype switching in vitro in response to a number of distinct stimuli. p50-/- B cells proliferated normally in response to dextran-anti-IgD Abs (alpha delta-dex) and membrane-bound, but not soluble, CD40 ligand (CD40), and they were virtually unresponsive to LPS when compared with control B cells. p50-/- B cells secreted markedly reduced Ig in response to alpha delta-dex or mCD40L in the presence of IL-4 + IL-5, despite their relatively normal proliferative rates, whereas normal Ig secretion was restored by the combination of alpha delta-dex and CD40L. p50-/- B cells expressed normal steady-state levels of germ-line CH gamma 1 and CH alpha RNA but markedly reduced germ-line CH gamma 3 and CH epsilon RNA upon appropriate stimulation. Although p50-/- B cells underwent substantial switching to IgG1, a marked reduction in the switch to IgG3 and IgE, as IgA, was observed. These data are the first to demonstrate key, independent roles for p50/NF-kappaB in normal B cell maturation to Ig secretion, germ-line CH gene activation, and Ig class switching, as well as mitogenesis, and provide a powerful and well-defined in vitro model system for studying the role of p50/NF-kappaB in a wide range of normal cellular functions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598461

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  91 in total

1.  NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

Authors:  D C Guttridge; C Albanese; J Y Reuther; R G Pestell; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 2.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

3.  Two new isotype-specific switching activities detected for Ig class switching.

Authors:  Limei Ma; Henry H Wortis; Amy L Kenter
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

4.  T-bet regulates IgG class switching and pathogenic autoantibody production.

Authors:  Stanford L Peng; Susanne J Szabo; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 5.  NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

Authors:  Jorge Caamaño; Christopher A Hunter
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

6.  Imprinting the fate of antigen-reactive B cells through the affinity of the B cell receptor.

Authors:  Brian P O'Connor; Laura A Vogel; Weijun Zhang; William Loo; Danielle Shnider; Evan F Lind; Michelle Ratliff; Randolph J Noelle; Loren D Erickson
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

7.  Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury.

Authors:  Fiona Oakley; Jelena Mann; Sarah Nailard; David E Smart; Narendra Mungalsingh; Christothea Constandinou; Shakir Ali; Susan J Wilson; Harry Millward-Sadler; John P Iredale; Derek A Mann
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  The ability of CD40L, but not lipopolysaccharide, to initiate immunoglobulin switching to immunoglobulin G1 is explained by differential induction of NF-kappaB/Rel proteins.

Authors:  S C Lin; H H Wortis; J Stavnezer
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  The role of nuclear factor-kappaB essential modulator (NEMO) in B cell development and survival.

Authors:  Shinyop Kim; Ross N A La Motte-Mohs; Dorothea Rudolph; Juan Carlos Zuniga-Pflucker; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

Review 10.  The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target.

Authors:  Yonghui Yu; Yu Wan; Chuanshu Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-06       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.